Literature DB >> 6683536

[Specificity and precision of a radioimmunoassay of dihydroergotoxine in plasma].

W Loh, B G Woodcock.   

Abstract

For the quantitative and qualitative determination of dihydroergotoxine methanesulphonate (DCCK) a radioimmunoassay was developed. This method involves use of an antibody against the dihydrolysergic acid moiety and an 125I-labelled dihydrolysergic tracer. The differentiation of dihydroergopeptides, lysergic acid and the ergopeptides was obtained by modification of extraction methods already published. The assay procedure detects around 10 pg/ml dihydroergotoxine. Dihydrolysergic acid and lysergic acid are not detectable up to about 6 ng/ml. Ergometrine and alpha-ergocryptine show cross-reactivities of 14% and 7.5%, respectively. All dihydroergopeptides included in dihydroergotoxine show the same cross-reactivity as dihydroergotoxine itself. Intra- and inter-assay variations were approximately 12% and 13%, respectively.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683536

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  2 in total

1.  Absorption kinetics of dihydroergotoxine following oral administration to man.

Authors:  B G Woodcock; N Rietbrock; W Loh; W D Habedank
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

2.  The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects.

Authors:  P Dominiak; J Grevel; E Abisch; H Grobecker; H J Dennler; D Welzel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.